There is so much to be excited about the amazing products and intellectual property of this company. My only concern is if there is the plan to grow into a world class health care and biotech, why have the board not communicated this to shareholders. Unblinded vax results should be accompanied by a date when it is expected to be a stand alone cash flow positive business. They would surely have done the modeling and know the timeline.
What is the plan?
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$12.30 |
Change
0.295(2.46%) |
Mkt cap ! $263.1M | |||
| Open | High | Low | Value | Volume |
| $12.49 | $12.99 | $12.21 | $138.0K | 11.13K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 150 | $12.21 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $12.37 | 589 | 2 |
View Market Depth
| Last trade - 13.34pm 03/10/2024 (20 minute delay) ? |
| AVR (ASX) Chart |